Concepts (183)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vascular Surgical Procedures | 9 | 2022 | 245 | 1.220 |
Why?
|
| Aortic Aneurysm, Abdominal | 6 | 2022 | 225 | 0.850 |
Why?
|
| Endovascular Procedures | 8 | 2022 | 583 | 0.840 |
Why?
|
| Ischemia | 6 | 2025 | 195 | 0.780 |
Why?
|
| Blood Vessel Prosthesis Implantation | 6 | 2022 | 283 | 0.780 |
Why?
|
| Peripheral Arterial Disease | 5 | 2025 | 158 | 0.780 |
Why?
|
| Lost to Follow-Up | 2 | 2019 | 6 | 0.710 |
Why?
|
| Lower Extremity | 5 | 2023 | 146 | 0.640 |
Why?
|
| Postoperative Care | 1 | 2016 | 116 | 0.520 |
Why?
|
| Computed Tomography Angiography | 3 | 2021 | 118 | 0.470 |
Why?
|
| Vascular Grafting | 3 | 2025 | 39 | 0.410 |
Why?
|
| Surgeons | 3 | 2020 | 157 | 0.400 |
Why?
|
| Endarterectomy, Carotid | 3 | 2022 | 87 | 0.360 |
Why?
|
| Ultrasonography, Doppler, Duplex | 2 | 2021 | 46 | 0.340 |
Why?
|
| Time Factors | 11 | 2025 | 3663 | 0.320 |
Why?
|
| Aortic Aneurysm, Thoracic | 2 | 2021 | 105 | 0.320 |
Why?
|
| Carotid Stenosis | 2 | 2021 | 105 | 0.310 |
Why?
|
| Relative Value Scales | 2 | 2020 | 16 | 0.310 |
Why?
|
| Risk Factors | 12 | 2025 | 5161 | 0.300 |
Why?
|
| Treatment Outcome | 13 | 2025 | 5352 | 0.300 |
Why?
|
| Intermittent Claudication | 2 | 2019 | 51 | 0.300 |
Why?
|
| Retrospective Studies | 16 | 2023 | 6204 | 0.300 |
Why?
|
| Fee-for-Service Plans | 2 | 2020 | 67 | 0.300 |
Why?
|
| Thrombosis | 2 | 2021 | 191 | 0.290 |
Why?
|
| Health Services Needs and Demand | 2 | 2020 | 215 | 0.290 |
Why?
|
| Saphenous Vein | 2 | 2025 | 46 | 0.270 |
Why?
|
| Blood Vessel Prosthesis | 4 | 2022 | 212 | 0.260 |
Why?
|
| Registries | 5 | 2021 | 811 | 0.230 |
Why?
|
| Aged, 80 and over | 9 | 2021 | 5291 | 0.230 |
Why?
|
| Aorta, Abdominal | 2 | 2022 | 59 | 0.230 |
Why?
|
| Aged | 14 | 2025 | 13879 | 0.230 |
Why?
|
| Aortography | 2 | 2022 | 55 | 0.210 |
Why?
|
| Risk Assessment | 7 | 2025 | 1957 | 0.200 |
Why?
|
| Internship and Residency | 2 | 2021 | 749 | 0.200 |
Why?
|
| Humans | 29 | 2025 | 60999 | 0.190 |
Why?
|
| Insulins | 1 | 2022 | 15 | 0.190 |
Why?
|
| Natural Language Processing | 1 | 2022 | 68 | 0.190 |
Why?
|
| Medicare | 3 | 2022 | 603 | 0.190 |
Why?
|
| Walking | 1 | 2023 | 232 | 0.180 |
Why?
|
| Health Facilities | 1 | 2020 | 43 | 0.180 |
Why?
|
| Arteriovenous Shunt, Surgical | 1 | 2020 | 44 | 0.180 |
Why?
|
| Current Procedural Terminology | 2 | 2020 | 16 | 0.180 |
Why?
|
| Angioplasty, Balloon | 1 | 2020 | 58 | 0.170 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2020 | 46 | 0.170 |
Why?
|
| Tertiary Care Centers | 1 | 2021 | 105 | 0.170 |
Why?
|
| Iatrogenic Disease | 1 | 2020 | 57 | 0.170 |
Why?
|
| Documentation | 2 | 2018 | 130 | 0.170 |
Why?
|
| Prosthesis Design | 4 | 2022 | 210 | 0.170 |
Why?
|
| Data Accuracy | 2 | 2018 | 27 | 0.170 |
Why?
|
| Celiac Artery | 1 | 2019 | 14 | 0.160 |
Why?
|
| Popliteal Artery | 1 | 2019 | 24 | 0.160 |
Why?
|
| Clinical Coding | 2 | 2018 | 43 | 0.160 |
Why?
|
| Catheterization, Central Venous | 1 | 2020 | 88 | 0.160 |
Why?
|
| Infection Control | 1 | 2020 | 100 | 0.160 |
Why?
|
| Education, Medical, Graduate | 2 | 2021 | 321 | 0.160 |
Why?
|
| Aneurysm | 1 | 2019 | 54 | 0.160 |
Why?
|
| Aortic Aneurysm | 1 | 2019 | 83 | 0.160 |
Why?
|
| Male | 13 | 2025 | 28463 | 0.150 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2020 | 116 | 0.150 |
Why?
|
| New England | 2 | 2016 | 268 | 0.150 |
Why?
|
| Vascular Patency | 4 | 2021 | 133 | 0.150 |
Why?
|
| General Surgery | 1 | 2021 | 193 | 0.150 |
Why?
|
| Atherectomy | 1 | 2018 | 8 | 0.150 |
Why?
|
| Middle Aged | 9 | 2025 | 16875 | 0.150 |
Why?
|
| Chi-Square Distribution | 2 | 2016 | 411 | 0.150 |
Why?
|
| Forms and Records Control | 1 | 2018 | 13 | 0.150 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 2 | 2008 | 46 | 0.150 |
Why?
|
| Acute Kidney Injury | 1 | 2019 | 133 | 0.150 |
Why?
|
| Diagnosis-Related Groups | 1 | 2018 | 87 | 0.150 |
Why?
|
| Medical Records | 1 | 2018 | 141 | 0.150 |
Why?
|
| Female | 13 | 2025 | 31733 | 0.140 |
Why?
|
| International Classification of Diseases | 1 | 2018 | 143 | 0.140 |
Why?
|
| Physicians | 1 | 2022 | 444 | 0.140 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 199 | 0.140 |
Why?
|
| United States | 8 | 2025 | 7659 | 0.140 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 213 | 0.140 |
Why?
|
| Multivariate Analysis | 2 | 2016 | 933 | 0.140 |
Why?
|
| Diabetes Mellitus | 1 | 2022 | 541 | 0.140 |
Why?
|
| Physician's Role | 1 | 2018 | 122 | 0.140 |
Why?
|
| Needs Assessment | 1 | 2018 | 191 | 0.140 |
Why?
|
| Endoleak | 3 | 2021 | 37 | 0.130 |
Why?
|
| Databases, Factual | 4 | 2021 | 854 | 0.130 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2018 | 722 | 0.120 |
Why?
|
| Terminology as Topic | 1 | 2016 | 139 | 0.120 |
Why?
|
| Odds Ratio | 1 | 2016 | 778 | 0.120 |
Why?
|
| Reproducibility of Results | 4 | 2021 | 1605 | 0.110 |
Why?
|
| Quality Improvement | 1 | 2018 | 429 | 0.110 |
Why?
|
| Patient Care Team | 1 | 2016 | 335 | 0.110 |
Why?
|
| Logistic Models | 1 | 2016 | 1272 | 0.100 |
Why?
|
| Predictive Value of Tests | 3 | 2021 | 1061 | 0.100 |
Why?
|
| Hernia, Diaphragmatic, Traumatic | 1 | 2012 | 1 | 0.100 |
Why?
|
| Budd-Chiari Syndrome | 1 | 2012 | 5 | 0.100 |
Why?
|
| Cell Proliferation | 3 | 2010 | 948 | 0.090 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2012 | 104 | 0.090 |
Why?
|
| Workload | 2 | 2021 | 122 | 0.090 |
Why?
|
| Indazoles | 1 | 2010 | 12 | 0.090 |
Why?
|
| Sarcoma, Ewing | 1 | 2010 | 11 | 0.090 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2010 | 13 | 0.090 |
Why?
|
| Accidental Falls | 1 | 2012 | 154 | 0.090 |
Why?
|
| Phenylurea Compounds | 1 | 2010 | 30 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2010 | 32 | 0.080 |
Why?
|
| Limb Salvage | 2 | 2025 | 68 | 0.080 |
Why?
|
| Reoperation | 2 | 2025 | 271 | 0.080 |
Why?
|
| Bone Neoplasms | 1 | 2010 | 116 | 0.080 |
Why?
|
| Leukemia, Myeloid | 1 | 2008 | 32 | 0.080 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2008 | 47 | 0.080 |
Why?
|
| Postoperative Complications | 3 | 2021 | 1185 | 0.080 |
Why?
|
| Prospective Studies | 3 | 2022 | 3190 | 0.080 |
Why?
|
| Health Care Surveys | 2 | 2020 | 283 | 0.080 |
Why?
|
| Critical Illness | 2 | 2025 | 343 | 0.070 |
Why?
|
| Gene Knockdown Techniques | 1 | 2008 | 195 | 0.070 |
Why?
|
| Leukemia | 1 | 2007 | 56 | 0.070 |
Why?
|
| Graft Occlusion, Vascular | 2 | 2021 | 60 | 0.070 |
Why?
|
| Hematopoiesis | 1 | 2007 | 125 | 0.070 |
Why?
|
| Stents | 2 | 2021 | 459 | 0.070 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2021 | 398 | 0.070 |
Why?
|
| Gene Expression Profiling | 1 | 2008 | 721 | 0.060 |
Why?
|
| Severity of Illness Index | 2 | 2021 | 1515 | 0.060 |
Why?
|
| Acute Disease | 2 | 2019 | 675 | 0.060 |
Why?
|
| Comorbidity | 2 | 2018 | 1116 | 0.060 |
Why?
|
| Survival Rate | 2 | 2021 | 812 | 0.050 |
Why?
|
| Massachusetts | 2 | 2019 | 2122 | 0.050 |
Why?
|
| Angioplasty | 1 | 2022 | 48 | 0.050 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2022 | 43 | 0.050 |
Why?
|
| Paraparesis | 1 | 2021 | 9 | 0.050 |
Why?
|
| Renal Artery | 1 | 2021 | 30 | 0.050 |
Why?
|
| Iliac Artery | 1 | 2021 | 46 | 0.050 |
Why?
|
| Intraoperative Complications | 1 | 2021 | 83 | 0.040 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2021 | 77 | 0.040 |
Why?
|
| Clinical Decision-Making | 1 | 2021 | 143 | 0.040 |
Why?
|
| Fasciotomy | 1 | 2019 | 8 | 0.040 |
Why?
|
| Ligation | 1 | 2019 | 35 | 0.040 |
Why?
|
| Blood Flow Velocity | 1 | 2019 | 70 | 0.040 |
Why?
|
| Retreatment | 1 | 2019 | 46 | 0.040 |
Why?
|
| Thrombectomy | 1 | 2021 | 207 | 0.040 |
Why?
|
| Regional Blood Flow | 1 | 2019 | 109 | 0.040 |
Why?
|
| Observer Variation | 1 | 2019 | 212 | 0.040 |
Why?
|
| Betacoronavirus | 1 | 2020 | 173 | 0.040 |
Why?
|
| Host-Pathogen Interactions | 1 | 2020 | 238 | 0.040 |
Why?
|
| Reimbursement Mechanisms | 1 | 2018 | 41 | 0.040 |
Why?
|
| Certification | 1 | 2018 | 50 | 0.040 |
Why?
|
| Anticoagulants | 1 | 2021 | 490 | 0.030 |
Why?
|
| Patient Admission | 1 | 2018 | 191 | 0.030 |
Why?
|
| Prognosis | 1 | 2021 | 1631 | 0.030 |
Why?
|
| Health Care Costs | 1 | 2018 | 211 | 0.030 |
Why?
|
| Clinical Competence | 1 | 2021 | 703 | 0.030 |
Why?
|
| Leadership | 1 | 2018 | 204 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2018 | 491 | 0.030 |
Why?
|
| Pandemics | 1 | 2020 | 639 | 0.030 |
Why?
|
| Health Status | 1 | 2018 | 456 | 0.030 |
Why?
|
| Healthcare Disparities | 1 | 2018 | 332 | 0.030 |
Why?
|
| Length of Stay | 1 | 2018 | 784 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2016 | 320 | 0.030 |
Why?
|
| Cell Line | 2 | 2008 | 2015 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2020 | 2547 | 0.030 |
Why?
|
| Stroke | 1 | 2021 | 1144 | 0.020 |
Why?
|
| Hepatectomy | 1 | 2012 | 59 | 0.020 |
Why?
|
| Thoracic Surgical Procedures | 1 | 2012 | 33 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2013 | 691 | 0.020 |
Why?
|
| Suture Techniques | 1 | 2012 | 88 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2010 | 183 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2010 | 457 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2010 | 309 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2010 | 513 | 0.020 |
Why?
|
| Genes, cdc | 1 | 2008 | 15 | 0.020 |
Why?
|
| Genes, Neoplasm | 1 | 2008 | 24 | 0.020 |
Why?
|
| K562 Cells | 1 | 2008 | 58 | 0.020 |
Why?
|
| Response Elements | 1 | 2008 | 43 | 0.020 |
Why?
|
| Mice, Inbred NOD | 1 | 2010 | 517 | 0.020 |
Why?
|
| Cyclin A | 1 | 2007 | 8 | 0.020 |
Why?
|
| Cyclin D1 | 1 | 2007 | 21 | 0.020 |
Why?
|
| Gene Regulatory Networks | 1 | 2008 | 144 | 0.020 |
Why?
|
| Histones | 1 | 2008 | 466 | 0.020 |
Why?
|
| Mice | 2 | 2010 | 10362 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2010 | 649 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2012 | 1541 | 0.010 |
Why?
|
| RNA Interference | 1 | 2007 | 593 | 0.010 |
Why?
|
| Adult | 1 | 2019 | 16226 | 0.010 |
Why?
|
| Young Adult | 1 | 2012 | 4433 | 0.010 |
Why?
|
| Animals | 2 | 2010 | 19839 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2007 | 1550 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2007 | 3236 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2010 | 2905 | 0.010 |
Why?
|